I know you can't really go with this factor, but I think it accounts for something.
The science behind the antibody treatment is simple, and it's readily apparent why it should work. Obviously it would be prudent to have the statistics, but I don't think the treatment should be discounted if there is only anecdotal evidence presented, as the logic behind its efficacy is straightforward.